On January 24, 1996, the Food and Drug Administration approved human consumption of a synthetic, calorie free fat substitute called what?

On that date in 1996, the Food and Drug Administration gave its approval to Olestra, a synthetic fat substitute developed by Procter & Gamble. Chemically, Olestra is a sucrose polyester, created by bonding fatty acids to a sugar molecule. This unique structure makes the molecule too large and complex for the body's digestive enzymes to break down. As a result, it passes through the digestive system completely unabsorbed, contributing zero calories or fat to a person's diet, making it seem like a dieter's dream.

Marketed under the brand name Olean, the substance was most famously used in the Frito-Lay line of "WOW!" chips, which promised consumers the full flavor of their favorite fried snacks with significantly less fat. The dream, however, came with a significant downside. Because Olestra is an undigested fat, it could cause unpleasant gastrointestinal side effects, including abdominal cramping and loose stools. It also interfered with the body's ability to absorb essential fat-soluble vitamins like A, D, E, and K.

Due to these issues, the FDA initially required all products containing Olestra to carry an explicit warning label about its potential side effects. While the warning label requirement was eventually removed in 2003, public enthusiasm had already faded. Olestra remains a fascinating, if cautionary, tale in the history of food science, where a clever chemical solution ran into the complex realities of human digestion.